Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity
This economic evaluation estimates the 10-year net fiscal impact of expanded Medicare coverage for glucagon-like peptide-1 (GLP-1) receptor agonists for obesity treatment.
from JAMA Health Forum New Online https://ift.tt/xgCX6tT
from JAMA Health Forum New Online https://ift.tt/xgCX6tT
Comments
Post a Comment